Related Experiment Videos
Transcorneal oxygen therapy for glaucoma associated with sickle cell hyphema
1Delmarva Vitreoretinal Center, Salisbury, Maryland, USA. benner@shore.intercom.net
Purpose:
To study three patients with glaucoma caused by sickle cell hyphema who were successfully treated with transcorneal oxygen therapy.
Methods:
Case reports. Three patients with increased intraocular pressure caused by sickle cell hyphema were administered transcorneal oxygen therapy using humidified oxygen at a flow rate that ranged from 1 to 3 l/minute.
Results:
All three patients had a dramatic reduction in their intraocular pressure within hours of receiving oxygen therapy. No complications were associated with the oxygen therapy.
Conclusion:
Transcorneal oxygen therapy can reduce intraocular pressure in patients with glaucoma from sickle cell hyphema. Further study is warranted to evaluate this new therapy.